Picture of RIT Capital Partners logo

RCP RIT Capital Partners News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeLarge Cap

REG - RIT Cap. Partners - Net Asset Value(s)

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260205:nRSE7717Ra&default-theme=true

RNS Number : 7717R  RIT Capital Partners PLC  05 February 2026

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

5 February 2026

December 2025 Preliminary Unaudited Net Asset Value

RIT Capital Partners plc ("RIT") announces that its preliminary unaudited
diluted NAV as at 31 December 2025 (with debt at fair value) was 2,921p
per £1 ordinary share (30 November 2025: 2,899p). This represents a +0.8%
total return for the month, outperforming the ACWI (50% £) at +0.1%.

The preliminary 31 December 2025 NAV is equivalent to a NAV per share total
return for the year of +13.5%, with double-digit returns across all three
investment pillars (Quoted Equities, Private Investments and Uncorrelated
Strategies). Our annualised NAV per share total return since inception is
+10.6%, underscoring our commitment to delivering healthy, long-term returns
for our shareholders.

As is customary at this point in our year-end process, the preliminary NAV and
associated performance numbers for 2025 are estimates, and subject to
potential adjustment and audit. Full details will be included in the 2025
Annual Report and Accounts, which is expected to be published by early March
2026.

December 2025 Performance Highlights

RIT delivered resilient performance, demonstrating the benefits of our
diversified global portfolio. Performance was led by Private Investments and
Uncorrelated Strategies which contributed positively to NAV. Quoted Equities
detracted modestly during the month, while the continued strengthening of
sterling against the US dollar resulted in a negative translation effect on
our global portfolio.

 -  In Quoted Equities, weakness in technology and biotech stocks was partially
    offset by strong performance in our quality theme and emerging markets related
    holdings.
 -  Private Investments delivered positive returns, helped by an uplift in
    December valuations of our direct holdings. As of 31 December 2025, more than
    99% of our private funds were held at 30 September 2025 reported valuations
    and all private direct holdings were valued as at 31 December 2025, in line
    with our valuation policy.
 -  Uncorrelated Strategies, which acts as a steady diversifier of returns,
    contributed positively to our NAV, supported by gold and credit.
 -  We continued our share buyback programme, buying back £13.4m or approximately
    593,000 shares in December, adding an estimated +9bps accretion to NAV. As at
    31 December 2025, the total share capital repurchased through buybacks since
    the start of the year amounted to 3% at a total value of £89.0m.

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

Nathan Brown, Vicki Paine

T: 020 7260 1000

 

JP Morgan Cazenove Limited (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group (Media enquiries):

Nick Cosgrove, Peter Hesse

T: 020 7404 5959

E: RIT@BrunswickGroup.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVDZLFBQLLLBBX



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on RIT Capital Partners

See all news